Waystar Holding, a healthcare technology company, received a buy rating due to its impressive 18% revenue growth, 34% subscription growth, and a 42.8% adjusted EBITDA margin. The company's expanding AI capabilities and recent acquisition of Iodine Software enhance its platform value and increase its addressable market by over 15%. With subscription revenue and a net revenue retention rate of 108%, Waystar demonstrates a stable recurring revenue base supported by strong client expansion and upselling. Its valuation remains attractive with a forward P/E of 15.01x and EV/EBITDA of 11.25x, alongside upwardly revised guidance for 2026, indicating potential for further growth.
Arete Research downgraded Uber's stock from Buy to Neutral with a $74 price target, citing an expected 64.95% drop in earnings per share to $1.09 despite 9.6% revenue growth to $14.76 billion. Uber faces new competition from Tesla's Cybercab, which o...
Wealthfront Corporation reported better-than-expected Q2 2026 earnings with $0.10 EPS versus $0.08 estimated and revenue of $91.87 million surpassing $91.53 million estimates. The company’s total platform assets grew 12% year-over-year to $99 billion...
Bitcoin traded near $80,000 after testing that level early September, with Ethereum and XRP also rising. Mexican billionaire Ricardo Salinas Pliego reiterated his bullish view, forecasting Bitcoin could reach $1.86 million by matching gold's market v...
Voyageur Pharmaceuticals has reached its first milestone in a collaboration with Bayer by submitting an approved feasibility plan, triggering a $1 million non-dilutive payment. This follows an earlier $350,000 payment, totaling $1.35 million of the $...
Eigen Labs hosted a quantum circuit optimization challenge that outperformed Google's benchmark for breaking Bitcoin and Ethereum cryptography by about 50%. Over 100 participants, including Ethereum Foundation and StarkWare researchers, improved the ...
